Purpose To assess noninfectious uveitis (NIU) risk after coronavirus disease 2019 (COVID-
19) vaccination in patients without a history of uveitis. Design A retrospective matched cohort …

Purpose To investigate the incidence and risk of noninfectious uveitis (NIU) following COVID-
19 vaccination compared with an unvaccinated, uninfected control group. Design …

Purpose To identify rates of uveitis reactivation both before and after the coronavirus
disease (COVID) 2019 vaccine in subjects with a previous diagnosis of uveitis. Design …

Purpose To assess the risk of vaccine-associated uveitis (VAU) after severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and evaluate uveitis onset …

Objectives Several studies suggested that coronavirus disease 2019 (COVID-19)
vaccination may lead to uveitis, a vision-threatening condition often associated with a variety …

Purpose COVID-19 vaccines are currently undergoing long-term safety monitoring, including
for ocular side effects. Uveitis following vaccination has been described previously with …

Background We report vaccine and booster-related uveitis in Singapore, a country with high
vaccination and booster rates to highlight the differences and potential role of prophylactic …

Numerous complications following COVID-19 vaccination has been reported in the
literature, with an increasing body of evidence reporting vaccination-associated uveitis …

Purpose To assess the risk of vaccine-associated uveitis (VAU) following SARS-CoV-2
vaccination and evaluate uveitis onset interval and clinical presentations in the patients …

Purpose To assess the association between BNT162b2 mRNA coronavirus disease 2019
(COVID-19) vaccine and the risk of active noninfectious uveitis (NIU). Design Retrospective …